id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-260218-add4i1c9	Bosch‐Amate, X	Retiform purpura as a dermatological sign of covid‐19 coagulopathy	2020-06-03		.txt	text/plain	448	36	43	Recalcati(1) asserted that 20.4% of infected patients developed cutaneous manifestations and Galván‐Casas et al(2) have recently proposed 5 clinical patterns (pseudo‐chilblain, vesicular, urticarial, maculopapular and livedo/necrosis). 6 Purpura, Raynaud's phenomenon, chilblain-like and erythema multiforme-like lesions in young asymptomatic patients have also been observed with this infection, although the connection with coagulopathy is unknown. 7, 8 Our patient presented with retiform purpura as a cutaneous manifestation of COVID-19 coagulopathy. 9 Our case highlights the concomitant presentation of cutaneous microthrombi presenting as retiform purpura and macrothrombi presenting as pulmonary thromboembolism in the setting of COVID-19 coagulopathy. From now on, we will have to include COVID-19 infection in the differential diagnosis of retiform purpura. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis	./cache/cord-260218-add4i1c9.txt	./txt/cord-260218-add4i1c9.txt